Fig. 1: Overall survival comparison of CML patients with cryptic vs. non-cryptic der(9)/der(22) and complex karyotype (CK) vs. non-CK. | Modern Pathology

Fig. 1: Overall survival comparison of CML patients with cryptic vs. non-cryptic der(9)/der(22) and complex karyotype (CK) vs. non-CK.

From: Chronic myeloid leukemia with insertion-derived BCR–ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis

Fig. 1

a Cryptic der(9)/der(22) (n = 23) vs. non-cryptic der(9)/der(22) (n = 15). The mean survival/follow-up lengths were 78.2 months (range 12–242 months) in the group with cryptic aberration and 96.8 months (range 11–200 months) in the group with non-cryptic aberration respectively. No statistically significant difference for overall survival was observed between these two groups (p = 0.21). b Complex karyotype (CK) (n = 14) vs. non-CK (n = 24). The mean survival/follow-up lengths were 87.6 months (range 11–187 months) in the group with complex karyotype (CK) and 84.4 months (range 12–242 months) in the group with non-CK respectively. No statistically significant difference for overall survival was observed between these two groups (p = 0.97).

Back to article page